{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T02:36:46Z","timestamp":1771295806960,"version":"3.50.1"},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,3]]},"abstract":"<jats:sec>\n            <jats:title>Introduction:<\/jats:title>\n            <jats:p>Pineal parenchymal tumor of intermediate differentiation (PPTID) is an uncommon tumor of the pineal gland. Although this behaves as a grade II\/III tumor, the exact clinical behavior is not well known. There is no well-established pathologic factor that can predict the behavior of PPTID.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Aim and Objective:<\/jats:title>\n            <jats:p>The aim of this study was to determine the pathologic prognostic factors in PPTID.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Materials and Methods:<\/jats:title>\n            <jats:p>All PPTID cases diagnosed between 2006 and 2016 were analyzed retrospectively. Immunohistochemistry for synaptophysin, neurofilament protein (NFP), glial fibrillar acid protein, NeuN, and Ki-67 were performed in all cases. Cases were classified arbitrarily into low grade (mitosis &lt;4\/10 hpf and Ki-67 &lt;5%) and high grade (mitosis \u22654\/10 hpf and Ki-67 \u22655%). Clinical details including follow-up information were retrieved from the patients\u2019 files.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>A total of 16 patients (6 low grade and 10 high grade) were included in this study. The age ranged from 2 to 55 years (average, 28.2) with a mild male preponderance (male:female, 1.67:1). All cases showed strong and diffuse positivity for synaptophysin. Focal NFP positivity was seen in 2 low-grade and 3 high-grade tumors. Only 2 cases showed focal NeuN positivity. Average Ki-67 index was 1.7% and 12.6% in low-grade and high-grade tumors, respectively. All patients with low-grade tumor were alive without recurrence. Among the patients with high-grade tumors, 2 had local recurrence, 1 had spinal metastasis, and 3 patients died.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Mitosis and Ki-67 proliferation index are the most important pathologic prognostic factors in PPTID. NFP expression does not carry any prognostic significance.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/pai.0000000000000565","type":"journal-article","created":{"date-parts":[[2017,8,10]],"date-time":"2017-08-10T10:30:49Z","timestamp":1502361049000},"page":"210-215","source":"Crossref","is-referenced-by-count":22,"title":["Pathologic Prognostic Factors of Pineal Parenchymal Tumor of Intermediate Differentiation"],"prefix":"10.1097","volume":"27","author":[{"given":"Debajyoti","family":"Chatterjee","sequence":"first","affiliation":[{"name":"Histopathology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khushboo","family":"Lath","sequence":"additional","affiliation":[{"name":"Histopathology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Navneet","family":"Singla","sequence":"additional","affiliation":[{"name":"Neurosurgery"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Narendra","family":"Kumar","sequence":"additional","affiliation":[{"name":"Radiotherapy, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bishan D.","family":"Radotra","sequence":"additional","affiliation":[{"name":"Histopathology"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R2-20231020","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1093\/neuonc\/now105","article-title":"Histopathologic review of pineal parenchymal tumors identifies novel morphologic subtypes and prognostic factors for outcome","volume":"19","author":"Raleigh","year":"2017","journal-title":"Neuro-oncol"},{"key":"R3-20231020","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1007\/s00381-016-3117-z","article-title":"Revisiting the metastatic potential of childhood pineal parenchymal tumor of intermediate differentiation: a case report","volume":"32","author":"Singla","year":"2016","journal-title":"Childs Nerv Syst"},{"key":"R4-20231020","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1136\/jnnp-2014-309805","article-title":"Twenty-seven cases of pineal parenchymal tumours of intermediate differentiation: mitotic count, Ki-67 labelling index and extent of resection predict prognosis","volume":"87","author":"Yu","year":"2016","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R5-20231020","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3109\/02688697.2015.1096912","article-title":"Pineal parenchymal tumours of intermediate differentiation\u2014an evidence-based review of a new pathological entity","volume":"30","author":"Amato-Watkins","year":"2016","journal-title":"Br J Neurosurg"},{"key":"R6-20231020","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3892\/mco.2013.231","article-title":"Pineal parenchymal tumor of intermediate differentiation: treatment outcomes of five cases","volume":"2","author":"Watanabe","year":"2014","journal-title":"Mol Clin Oncol"},{"key":"R7-20231020","doi-asserted-by":"crossref","first-page":"244","DOI":"10.4143\/crt.2013.45.3.244","article-title":"Successful treatment by chemotherapy of pineal parenchymal tumor with intermediate differentiation: a case report","volume":"45","author":"Yi","year":"2013","journal-title":"Cancer Res Treat"},{"key":"R8-20231020","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s10014-012-0089-x","article-title":"Pineal parenchymal tumor of intermediate differentiation with marked elevation of MIB-1 labeling index","volume":"29","author":"Fukuoka","year":"2012","journal-title":"Brain Tumor Pathol"},{"key":"R9-20231020","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1750-3639.2000.tb00242.x","article-title":"Pineal parenchymal tumors: a correlation of histological features with prognosis in 66 cases","volume":"10","author":"Jouvet","year":"2000","journal-title":"Brain Pathol"},{"key":"R10-20231020","doi-asserted-by":"crossref","first-page":"325","DOI":"10.5414\/NPP27325","article-title":"Pineal parenchymal tumors\u2014utility of immunohistochemical markers in prognostication","volume":"27","author":"Arivazhagan","year":"2008","journal-title":"Clin Neuropathol"},{"key":"R11-20231020","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.wneu.2013.02.007","article-title":"Clinicopathologic study of pineal parenchymal tumors of intermediate differentiation","volume":"81","author":"Ito","year":"2014","journal-title":"World Neurosurg"},{"key":"R12-20231020","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1111\/j.1440-1789.2012.01315.x","article-title":"Expression of O(6)-methylguanine DNA methyltransferase (MGMT) and immunohistochemical analysis of 12 pineal parenchymal tumors","volume":"32","author":"Kanno","year":"2012","journal-title":"Neuropathology"},{"key":"R13-20231020","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1365-2990.2011.01202.x","article-title":"Utility of Ki67 immunostaining in the grading of pineal parenchymal tumours: a multicentre study","volume":"38","author":"Fevre-Montange","year":"2012","journal-title":"Neuropathol Appl Neurobiol"},{"key":"R14-20231020","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1111\/j.1440-1789.2008.00994.x","article-title":"Pineal parenchymal tumor of intermediate differentiation showing malignant progression at relapse","volume":"29","author":"Kim","year":"2009","journal-title":"Neuropathology"},{"key":"R15-20231020","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.radonc.2016.10.025","article-title":"Patterns of care and survival outcomes in patients with pineal parenchymal tumor of intermediate differentiation: an individual patient data analysis","volume":"121","author":"Mallick","year":"2016","journal-title":"Radiother Oncol"},{"key":"R16-20231020","first-page":"26","article-title":"Are we over treating Pineal Parenchymal tumour with intermediate differentiation? Assessing the role of localised radiation therapy and literature review. Springerplus","volume":"5","author":"Das","year":"2016"}],"container-title":["Applied Immunohistochemistry &amp; Molecular Morphology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00129039-201903000-00007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T10:27:46Z","timestamp":1697797666000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00129039-201903000-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":15,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/pai.0000000000000565","relation":{},"ISSN":["1541-2016"],"issn-type":[{"value":"1541-2016","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]}}}